메뉴 건너뛰기




Volumn 88, Issue 1, 2002, Pages 87-93

Naloxone prevents increased atrial natriuretic peptide release during regional myocardial ischaemia and stunning in awake dogs

Author keywords

Antagonists opioid, naloxone; Brain, natriuretic peptide; Complications, myocardial stunning; Heart, atrial natriuretic peptide; Heart, ischaemia

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CEFAMANDOLE; FENTANYL; ISOFLURANE; KETAMINE; NALOXONE; OXYGEN; PIRITRAMIDE; PROPOFOL;

EID: 0036137432     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/88.1.87     Document Type: Article
Times cited : (5)

References (21)
  • 1
    • 0031834174 scopus 로고    scopus 로고
    • Natriuretic peptides: Physiology, therapeutic potential, and risk stratification in ischemic heart disease
    • (1998) Am Heart J , vol.135 , pp. 914-923
    • Stein, B.C.1    Levin, R.I.2
  • 5
    • 0007663297 scopus 로고    scopus 로고
    • Guide for the Care and Use of Laboratory Animals. Institute of Laboratory Animal Resources Commission on Life Sciences, National Research Council. Washington D.C.: National Academy Press. (NIH Publication No. 85-23, revised)
    • (1996)
  • 9
    • 0025924392 scopus 로고
    • Myocardial perfusion-contraction matching. Implications for coronary heart disease and hibernation
    • (1991) Circulation , vol.83 , pp. 1076-1083
    • Ross J., Jr.1
  • 16
    • 0030050969 scopus 로고    scopus 로고
    • Apparent desensitization of a sigma receptor sub-population in neonatal rat cardiac myocytes by pre-treatment with sigma receptor ligands
    • (1996) Eur J Pharmacol , vol.295 , pp. 275-280
    • Ela, C.1    Hasin, Y.2    Eilam, Y.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.